Cargando…
Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study “Innovative Treatments in Pneumonia”
BACKGROUND: Pneumonia is the leading infectious cause of death worldwide among children below 5 years of age. Clinical trials are conducted to determine optimal treatment; however, these trials often exclude children with comorbidities and severe illness. CONCLUSIONS: Given the paucity of data from...
Autores principales: | Ginsburg, Amy Sarah, May, Susanne, Nkwopara, Evangelyn, Ambler, Gwen, McCollum, Eric D, Mvalo, Tisungane, Phiri, Ajib, Lufesi, Norman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690162/ https://www.ncbi.nlm.nih.gov/pubmed/31359870 http://dx.doi.org/10.2196/13377 |
Ejemplares similares
-
Title Correction: Clinical Outcomes of Pneumonia and Other Comorbidities in Children Aged 2-59 Months in Lilongwe, Malawi: Protocol for the Prospective Observational Study “Innovative Treatments in Pneumonia”
por: Ginsburg, Amy Sarah, et al.
Publicado: (2019) -
Methods for conducting a double-blind randomized controlled clinical trial of three days versus five days of amoxicillin dispersible tablets for chest indrawing childhood pneumonia among children two to 59 months of age in Lilongwe, Malawi: a study protocol
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018) -
Geographically linked risk factors for enrolment into a fast breathing child pneumonia trial in Lilongwe, Malawi: an Innovative Treatments in Pneumonia (ITIP) secondary analysis
por: Nkwopara, Evangelyn, et al.
Publicado: (2019) -
Chest radiography in children aged 2–59 months enrolled in the Innovative Treatments in Pneumonia (ITIP) project in Lilongwe Malawi: a secondary analysis
por: Mvalo, Tisungane, et al.
Publicado: (2022) -
Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018)